Evidence map›Paper›PMID 40608836›Full record

ArticlePLoS neglected tropical diseases2025

Detecting soil-transmitted helminth and Schistosoma mansoni eggs in Kato-Katz stool smear microscopy images: A comprehensive in- and out-of-distribution evaluation of YOLOv7 variants.

Mohammed Aliy Mohammed, Esla Timothy Anzaku, Peter Kenneth Ward, Bruno Levecke, Janarthanan Krishnamoorthy, Wesley De Neve, Sofie Van Hoecke

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Development and validation of the AI-predictive ParaScoutEmerging microbes & infections · 2026
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohammed Aliy MohammedIDLab, Ghent University - imec, Ghent University, Ghent, Belgium.ORCID 0000-0003-1912-5666
Esla Timothy AnzakuDepartment of Electronics and Information Systems, Ghent University, Ghent, Belgium.
Peter Kenneth WardIDLab, Ghent University - imec, Ghent University, Ghent, Belgium.
Bruno LeveckeDepartment of Translational Physiology, Infectiology and Public Health, Ghent University, Merelbeke, Belgium.
Janarthanan KrishnamoorthySchool of Biomedical Engineering, Jimma Institute of Technology, Jimma University, Jimma, Ethiopia.
Wesley De NeveDepartment of Electronics and Information Systems, Ghent University, Ghent, Belgium.
Sofie Van HoeckeIDLab, Ghent University - imec, Ghent University, Ghent, Belgium.

Funding

Special Research Fund (BOF) at Ghent University
6 · The paper itself

Abstract

backgroundSoil-transmitted helminth (STH) and Schistosoma mansoni (S. mansoni) infections remain significant public health concerns in tropical and subtropical regions. Deep Convolutional Neural Networks (DCNNs) have already shown promising accuracy in identifying STH and S. mansoni eggs in the same, in-distribution (ID) settings. However, their performance in real-world, out-of-distribution (OOD) scenarios, characterized by variations in image capture devices and the appearance of previously unseen egg types, has not been thoroughly investigated. Assessing the robustness of DCNNs under these challenging conditions is crucial for ensuring their reliability in field diagnostics. METHODOLOGY: Our study addresses the gap in evaluating DCNNs for identifying STH and S. mansoni eggs by rigorously testing multiple variants of the You Only Look Once (YOLO) version 7 model under two OOD conditions: (i) a dataset shift due to a change in the image capture device, and (ii) a combination of this device change and the presence of two egg types not occurring during training. We adopted a 2 [Formula: see text] 3 montage data augmentation strategy to enhance OOD generalization. Additionally, we used the Toolkit for Identifying object Detection Errors (TIDE) and Gradient-weighted Class Activation Mapping (Grad-CAM) to perform a comprehensive analysis of the results. PRINCIPAL

findingsIn ID settings, YOLOv7-E6E outperformed other models, achieving an F1-score of 97.47%. For the OOD scenario involving only a change in the image capture device, the 2 [Formula: see text] 3 montage strategy significantly enhanced performance, increasing precision by 8%, recall by 14.85%, and mAP@IoU0.5 by 21.36%. However, for the more complex OOD scenario that involves both a change in the capture device and the introduction of two previously unseen egg types, the proposed augmentation technique, while beneficial, did not fully address the generalization challenges across all YOLOv7 variants, highlighting the necessity of testing beyond ID scenarios, on which state-of-the-art models predominantly focus. CONCLUSIONS/SIGNIFICANCE: This study underscores the critical importance of utilizing comprehensive test sets and conducting rigorous OOD evaluations when designing machine learning solutions for STH, S. mansoni or any other helminth infections. Understanding the true capabilities of DCNNs in real-world settings depends on such thorough testing. Expanding AI-driven diagnostic assessments to account for the complexities encountered in the field is essential for creating robust tools that can significantly contribute to the global elimination of STH and S. mansoni infections as public health problems by 2030, a goal put forth by the World Health Organization.

Indexed as

FecesHelminthiasisHelminthsMicroscopySchistosoma mansoniSchistosomiasis mansoniSoilAnimalsHumansNeural Networks, ComputerOvumParasite Egg CountSoil

Identifiers

PMID40608836
PMCPMC12251349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.